FATP1-IN-1 is primarily used in research settings to study lipid metabolism and its role in various metabolic disorders. It acts as an inhibitor of fatty acid transport protein 1 (FATP1), which is involved in the uptake and transport of long-chain fatty acids. By inhibiting FATP1, researchers can investigate the effects of reduced fatty acid uptake on cellular processes, particularly in conditions like obesity, diabetes, and cardiovascular diseases. This compound helps in understanding the molecular mechanisms underlying these disorders and in identifying potential therapeutic targets. Additionally, FATP1-IN-1 is utilized in preclinical studies to evaluate its efficacy and safety as a potential drug candidate for treating metabolic syndromes.